Chong Kun Dang Pharmaceutical (XKRX:185750) Total Operating Expense : ₩415,602 Mil (TTM As of Dec. 2023)

View and export this data going back to 2013. Start your Free Trial

What is Chong Kun Dang Pharmaceutical Total Operating Expense?

Chong Kun Dang Pharmaceutical's Total Operating Expense for the three months ended in Dec. 2023 was ₩118,177 Mil. Chong Kun Dang Pharmaceutical's Total Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 was ₩415,602 Mil.

Chong Kun Dang Pharmaceutical Total Operating Expense Historical Data

The historical data trend for Chong Kun Dang Pharmaceutical's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chong Kun Dang Pharmaceutical Total Operating Expense Chart

Chong Kun Dang Pharmaceutical Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Operating Expense

Get a 7-Day Free Trial

329,702.94

365,203.94

401,059.59

432,733.33

415,602.23

Chong Kun Dang Pharmaceutical Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Total Operating Expense	Get a 7-Day Free Trial															123,830.02	103,984.88	99,349.74	94,090.22	118,177.38

Chong Kun Dang Pharmaceutical Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.

Total Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩415,602 Mil.

Chong Kun Dang Pharmaceutical Total Operating Expense Related Terms

Thank you for viewing the detailed overview of Chong Kun Dang Pharmaceutical's Total Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Chong Kun Dang Pharmaceutical (XKRX:185750) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Chong Kun Dang Pharmaceutical Corp (XKRX:185750) » Definitions » Total Operating Expense

Traded in Other Exchanges

N/A

Address

368 Chungjungro-3Ga, Seodaemun-gu, Seoul, KOR, 120-756

Website

http://chongkundang.en.ec21.com

Chong Kun Dang Pharmaceutical Corp. is a manufacturer of antibiotics. The company manufactures and distributes over 130 ethical, OTC pharmaceuticals and pharmaceutical active ingredients, primarily focusing on the application of its advanced technologies in fermentation and organic synthesis. The product range includes Rifampicin (antituberculosis), DMCT (raw material for Minocycline), Cephalosporins, 7-ACA and other intermediates of Cephalosporins, Cyclosporin A (immunosuppressant) and Lovastatin (antihyperlipidaemic agent).

Chong Kun Dang Pharmaceutical (XKRX:185750) Headlines

No Headlines